Results from PIONEER: a randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis Radia, D. H., Sabato, V., Castells, M., Akin, C., Elberink, H., Tashi, T., George, T. I., Roche, M., DeAngelo, D. J., Gotlib, J. WILEY. 2021: 8-9

View details for Web of Science ID 000645412200008